Pharmacology

Action Mechanism of Action Reference
AGONIST Estrogen receptor agonist ISBN DailyMed

Indications

Mesh Heading Maximum Phase Mesh ID Reference
Breast Neoplasms 4 D001943 ClinicalTrials
Menopause 4 D008593 ClinicalTrials
Primary Ovarian Insufficiency 4 D016649 ClinicalTrials
Osteoporosis 4 D010024 ClinicalTrials
Hypertension 3 D006973 ClinicalTrials
Colonic Neoplasms 3 D003110 ClinicalTrials
Angina, Unstable 3 D000789 ClinicalTrials
Bone Diseases, Metabolic 3 D001851 ClinicalTrials
Hypercholesterolemia 3 D006937 ClinicalTrials
Hot Flashes 3 D019584 ClinicalTrials
Thrombosis 3 D013927 ClinicalTrials
Memory Disorders 3 D008569 ClinicalTrials
Turner Syndrome 3 D014424 ClinicalTrials
Alzheimer Disease 3 D000544 ClinicalTrials
Myocardial Infarction 3 D009203 ClinicalTrials
Stroke 3 D020521 ClinicalTrials
Coronary Disease 3 D003327 ClinicalTrials
Lupus Erythematosus, Systemic 3 D008180 ClinicalTrials
Anorexia Nervosa 3 D000856 ClinicalTrials
Myocardial Ischemia 3 D017202 ClinicalTrials
Diabetes Mellitus 3 D003920 ClinicalTrials
Endometrial Neoplasms 3 D016889 ClinicalTrials
Endometrial Hyperplasia 3 D004714 ClinicalTrials
Brain Injuries 2 D001930 ClinicalTrials
Urinary Bladder, Overactive 2 D053201 ClinicalTrials
Shock 2 D012769 ClinicalTrials
Prostatic Neoplasms 2 D011471 ClinicalTrials
Prostatic Neoplasms, Castration-Resistant 2 D064129 ClinicalTrials
Reperfusion Injury 1 D015427 ClinicalTrials

Related Entries

Mixture
Mixture
Mixture

Adverse Reactions

System Organ Classification (SOC)
Relative Frequency (%)
General disorders and administration site conditions
17.63
Nervous system disorders
10.05
Psychiatric disorders
9.21
Reproductive system and breast disorders
8.47
Injury, poisoning and procedural complications
6.9
Vascular disorders
6.28
Musculoskeletal and connective tissue disorders
5.62
Skin and subcutaneous tissue disorders
5.23
Investigations
3.85
Gastrointestinal disorders
3.77
Respiratory, thoracic and mediastinal disorders
3.44
Neoplasms benign, malignant and unspecified (incl cysts and polyps)
3.06
Infections and infestations
2.97
Cardiac disorders
2.45
Renal and urinary disorders
2.32
Immune system disorders
2.03

Cross References

Resources Reference
CAS NUMBER 12126-59-9
ChEMBL CHEMBL1201649
FDA SRS IU5QR144QX